Anne T. Bertrand

Paris, 75013, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

LAP1 Interactome Profiling Provides New Insights into LAP1's Physiological Functions.

LAP1 Interactome Profiling Provides New Insights into LAP1's Physiological Functions.

Journal: International journal of molecular sciences

Published: October 17, 2024

Recent insights in striated muscle laminopathies.

Recent insights in striated muscle laminopathies.

Journal: Current opinion in neurology

Published: July 11, 2024

Quantitative proteome analysis of LAP1-deficient human fibroblasts: A pilot approach for predicting the signaling pathways deregulated in LAP1-associated diseases.

Quantitative proteome analysis of LAP1-deficient human fibroblasts: A pilot approach for predicting the signaling pathways deregulated in LAP1-associated diseases.

Journal: Biochemistry and biophysics reports

Published: May 07, 2024

Cellular and Genomic Features of Muscle Differentiation from Isogenic Fibroblasts and Myoblasts.

Cellular and Genomic Features of Muscle Differentiation from Isogenic Fibroblasts and Myoblasts.

Journal: Cells

Published: June 30, 2023

Preclinical Advances of Therapies for Laminopathies.

Preclinical Advances of Therapies for Laminopathies.

Journal: Journal of clinical medicine

Published: October 01, 2021

Protein Kinase C Alpha Cellular Distribution, Activity, and Proximity with Lamin A/C in Striated Muscle Laminopathies.

Protein Kinase C Alpha Cellular Distribution, Activity, and Proximity with Lamin A/C in Striated Muscle Laminopathies.

Journal: Cells

Published: October 06, 2020

Consequences of Lmna Exon 4 Mutations in Myoblast Function.

Consequences of Lmna Exon 4 Mutations in Myoblast Function.

Journal: Cells

Published: April 13, 2020

Lamin A/C Assembly Defects in LMNA-Congenital Muscular Dystrophy Is Responsible for the Increased Severity of the Disease Compared with Emery-Dreifuss Muscular Dystrophy.

Lamin A/C Assembly Defects in LMNA-Congenital Muscular Dystrophy Is Responsible for the Increased Severity of the Disease Compared with Emery-Dreifuss Muscular Dystrophy.

Journal: Cells

Published: January 31, 2020

A Muscle Hybrid Promoter as a Novel Tool for Gene Therapy.

A Muscle Hybrid Promoter as a Novel Tool for Gene Therapy.

Journal: Molecular therapy. Methods & clinical development

Published: March 20, 2019

The Pathogenesis and Therapies of Striated Muscle Laminopathies.

The Pathogenesis and Therapies of Striated Muscle Laminopathies.

Journal: Frontiers in physiology

Published: August 17, 2018

Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy.

Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy.

Journal: Molecular therapy. Nucleic acids

Published: May 06, 2017

FHL1B Interacts with Lamin A/C and Emerin at the Nuclear Lamina and is Misregulated in Emery-Dreifuss Muscular Dystrophy.

FHL1B Interacts with Lamin A/C and Emerin at the Nuclear Lamina and is Misregulated in Emery-Dreifuss Muscular Dystrophy.

Journal: Journal of neuromuscular diseases

Published: December 03, 2016

Showing 1-12 of 24

Last Updated: 09/26/2026